Get started
Author

Chaoyang Sun

BRD4 Inhibition Is Synthetic Lethal with PARP Inhibitors through the Induction of Homologous Recombination Deficiency
2018 · Chaoyang Sun, Jun Yin, et al. · Cancer Cell · 300
PDF
Heterotypic CAF-tumor spheroids promote early peritoneal metastasis of ovarian cancer
2019 · Qinglei Gao, Zongyuan Yang, et al. · The Journal of Experimental Medicine · 236
Sequential Therapy with PARP and WEE1 Inhibitors Minimizes Toxicity while Maintaining Efficacy
2019 · Yong Fang, Daniel J. McGrail, et al. · Cancer Cell · 234
PDF
Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis
2020 · Yifan Meng, Wanrong Lu, et al. · Journal of Hematology & Oncology · 180
PDF
miR-9 Regulation of BRCA1 and Ovarian Cancer Sensitivity to Cisplatin and PARP Inhibition
2013 · Chaoyang Sun, Na Li, et al. · JNCI Journal of the National Cancer Institute · 170
The biodiversity Composition of Microbiome in Ovarian Carcinoma Patients
2019 · Bo Zhou, Chaoyang Sun, et al. · Scientific Reports · 145
PDF
Multiscale architecture design of 3D printed biodegradable Zn-based porous scaffolds for immunomodulatory osteogenesis
2024 · Shuang Li, Hongtao Yang, et al. · Nature Communications · 123
PDF
The trans-omics landscape of COVID-19
2021 · Peng Wu, Dongsheng Chen, et al. · Nature Communications · 123
PDF
Cisplatin-induced CCL5 secretion from CAFs promotes cisplatin-resistance in ovarian cancer via regulation of the STAT3 and PI3K/Akt signaling pathways
2016 · BO ZHOU, CHAOYANG SUN, et al. · International Journal of Oncology · 111
PDF
Proteome Instability Is a Therapeutic Vulnerability in Mismatch Repair-Deficient Cancer
2020 · Daniel J. McGrail, Jeannine Garnett, et al. · Cancer Cell · 110
PDF
Cancer stem cells and niches: challenges in immunotherapy resistance
2025 · Yonglong Pan, Chaoyi Yuan, et al. · Molecular Cancer · 101
TAGLN mediated stiffness-regulated ovarian cancer progression via RhoA/ROCK pathway
2021 · Xiao Wei, Hua Lou, et al. · Journal of Experimental & Clinical Cancer Research · 99
PDF
Metformin Suppresses Tumor Progression by Inactivating Stromal Fibroblasts in Ovarian Cancer
2018 · Sen Xu, Zongyuan Yang, et al. · Molecular Cancer Therapeutics · 97
The Role of BRCA Status on the Prognosis of Patients with Epithelial Ovarian Cancer: A Systematic Review of the Literature with a Meta-Analysis
2014 · Chaoyang Sun, Na Li, et al. · PLoS ONE · 96
PDF
Low Concentration of Quercetin Antagonizes the Cytotoxic Effects of Anti-Neoplastic Drugs in Ovarian Cancer
2014 · Na Li, Chaoyang Sun, et al. · PLoS ONE · 89
PDF
Characterization of the mutations of the K-ras, p53, p16, and SMAD4 genes in 15 human pancreatic cancer cell lines.
2001 · C Sun, T Yamato, et al. · Oncology Reports · 89
Multiomic analysis of cervical squamous cell carcinoma identifies cellular ecosystems with biological and clinical relevance
2023 · Junpeng Fan, Funian Lu, et al. · Nature Genetics · 88
PDF
miR-125b confers resistance of ovarian cancer cells to cisplatin by targeting pro-apoptotic Bcl-2 antagonist killer 1
2011 · Fanfei Kong, Chaoyang Sun, et al. · Journal of Huazhong University of Science and Technology [Medical Sciences] · 85
Spatial Heterogeneity of Infiltrating T Cells in High-Grade Serous Ovarian Cancer Revealed by Multi-Omics Analysis
2021 · Bin Yang, Xiong Li, et al. · Cell Reports Medicine · 82
MYC and the unfolded protein response in cancer: synthetic lethal partners in crime?
2020 · Tingting Zhang, Ningning Li, et al. · EMBO Molecular Medicine · 82
MCP-1/CCR-2 axis in adipocytes and cancer cell respectively facilitates ovarian cancer peritoneal metastasis
2019 · Chaoyang Sun, Xi Li, et al. · Oncogene · 82
WEE1 inhibition induces anti-tumor immunity by activating ERV and the dsRNA pathway
2021 · Ensong Guo, Rourou Xiao, et al. · The Journal of Experimental Medicine · 73
Drug screening model meets cancer organoid technology
2020 · Chen Liu, Tianyu Qin, et al. · Translational Oncology · 73
PDF
Akkermansia supplementation reverses the tumor-promoting effect of the fecal microbiota transplantation in ovarian cancer
2022 · Zizhuo Wang, Xu Qin, et al. · Cell Reports · 71
TFEB Mediates Immune Evasion and Resistance to mTOR Inhibition of Renal Cell Carcinoma via Induction of PD-L1
2019 · Cai Zhang, Yaqi Duan, et al. · Clinical Cancer Research · 68
Works count: 181
Citation count: 4,820
H-index: 41
I10-index: 83
Year
Topic
Type